跳至主要内容
临床试验/CTRI/2018/02/012134
CTRI/2018/02/012134已完成未知

Efficacy and safety of combined oral chelation with deferiprone and deferasirox on iron overload in children with transfusion dependent thalassemia

JIPMER0 个研究点目标入组 23 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
JIPMER
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Children of age 2-18 years with thalassemia and serum ferritin >= 1500ng/ml

排除标准

  • Children with
  • 1. Serum creatinine more than two times the upper limit for age
  • 2. Serum aspartate amino transferase and alanine amino transferase more than five times the upper limit for age
  • 3. Children with absolute neutrophil count less than 1500/mm3 and platelets less than 1 lakh/mm3
  • 4. Significant proteinuria defined by protein creatinine ratio more than 0.5
  • 5. Cardiac failure secondary to myocardial iron toxicity
  • 6. Previous history of allergic reaction to deferiprone or deferasirox

研究者

发起方
JIPMER

相似试验